Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Discover ways to make money from hobbies and turn your passions into profitable ventures. Start monetizing your interests now!
13,170 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
A top Wells Fargo strategist urges retail investors to look for buying opportunities on market dips sparked by Fed ti...
The July 4 grilling season unfolds amid higher meat prices and a wave of GLP-1 drug use that is reshaping what househ...
Public firms are embracing bitcoin as a reserve asset to diversify treasury holdings and hedge inflation. This report...
OpenAI teams with Broadcom to introduce its first custom AI accelerator, Jalapeño. The move signals a broader strateg...
Two iconic brands face different paths to recovery. This deep-dive weighs Nike 12-Year and Lululemon 8-Year dynamics,...
As markets wobble and political headwinds rise, a growing chorus argues that ceos have forgotten moderate. This piece...
Memory prices and AI data demands have put Micron and Sandisk in the spotlight. This piece breaks down what’s driving...
SpaceX is pursuing a bold mix of rockets, Starlink, and AI infrastructure. Yet heavy capital needs and a large debt l...
Discover how general mills (gis) 2026 could unfold, with a focus on brand strength, cost discipline, and capital allo...
A new Brookings-FED working paper casts doubt on ai’s $2.2 trillion deficit savings, warning that disruption and poli...
The SSA reports the average retirement benefit at $2,081 per month in 2026. This article explains how investors can b...